trending Market Intelligence /marketintelligence/en/news-insights/trending/9lAbYRjLG4yD_vLHIVAAkQ2 content esgSubNav
In This List

CSL appoints independent nonexecutive directors

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


CSL appoints independent nonexecutive directors

CSL Ltd. appointed Brian McNamee and Abbas Hussain as independent nonexecutive directors, effective Feb. 14, 2018.

McNamee will also serve as the board's chairman-elect. He previously served as the company's CEO and managing director, until his retirement in 2013.

Chairman John Shine will retire at the end of the 2018 annual general meeting, to be held October 2018.

Hussain was most recently global president, pharmaceutical at GlaxoSmithKline plc. He is currently a member of Immunocore Ltd.'s board.